Interferon-stimulated neutrophils as a predictor of immunotherapy response

Despite the remarkable success of anti-cancer immunotherapy, its effectiveness remains confined to a subset of patients—emphasizing the importance of predictive biomarkers in clinical decision-making and further mechanistic understanding of treatment response. Current biomarkers, however, lack the p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer cell 2024-02, Vol.42 (2), p.253-265.e12
Hauptverfasser:	Benguigui, Madeleine, Cooper, Tim J., Kalkar, Prajakta, Schif-Zuck, Sagie, Halaban, Ruth, Bacchiocchi, Antonella, Kamer, Iris, Deo, Abhilash, Manobla, Bar, Menachem, Rotem, Haj-Shomaly, Jozafina, Vorontsova, Avital, Raviv, Ziv, Buxbaum, Chen, Christopoulos, Petros, Bar, Jair, Lotem, Michal, Sznol, Mario, Ariel, Amiram, Shen-Orr, Shai S., Shaked, Yuval
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarker immunotherapy interferon melanoma neutrophils non-small cell lung cancer response STING
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!